Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.
Future Oncol
; 11(11): 1665-74, 2015.
Article
em En
| MEDLINE
| ID: mdl-26043218
ABSTRACT
AIM:
Providing epidemiological data and treatment of anemia in lung cancer patients undergoing first-line chemotherapy.METHODS:
Epidemiological, observational, retrospective and multicenter study carried out at 30 sites throughout Spain.RESULTS:
The prevalence of anemia (hemoglobin [Hb] level <12 g/dl) was 18.3% and the incidence 80.7%. Mean Hb levels were 13.4 g/dl (95% Cl 13.2-13.6) and 11.5 g/dl (95% Cl 11.3-11.7) at starting and at the end of chemotherapy, respectively. Of the 294 patients with anemia, 174 (59.2%) were treated. Erythropoiesis-stimulating agents were given to 90.2% patients, alone in 31.6% and combined iron in 39.7%, transfusion in 9.2% and iron and transfusion in 9.8%.CONCLUSION:
These results suggest an appropriate and rational use of erythropoiesis-stimulating agents in the treatment of chemotherapy-associated anemia in lung cancer patients. [corrected].Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Carcinoma Pulmonar de Células não Pequenas
/
Carcinoma de Pequenas Células do Pulmão
/
Hematínicos
/
Anemia
/
Neoplasias Pulmonares
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article